# OnCo record nct07483554 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07483554/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07483554", "NCT07483554" ;
  schema:name "IBI343 in Combination Therapy for Advanced Malignant Solid Tumors"@en ;
  schema:description "A phase 2 trial of IBI343, Gemcitabine in pancreatic ductal adenocarcinoma, run by Innovent Biologics (Suzhou) Co. Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07483554/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07483554> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-04-20" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/ibi343/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:companies <https://onco.cc/companies/innovent/> .